CUSIP: 86877M209
Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
28,557,874
-
Share change
-
-2,742,497
-
Total reported value
-
$23,399,191
-
Put/Call ratio
-
8.6%
-
Price per share
-
$0.82
-
Number of holders
-
75
-
Value change
-
-$2,286,577
-
Number of buys
-
27
-
Number of sells
-
39
Quarterly Holders Quick Answers
What is CUSIP 86877M209?
CUSIP 86877M209 identifies SURF - SURFACE ONCOLOGY INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2023
-
Previous quarter:
Q3 2022
Recent filing periods for CUSIP 86877M209:
Institutional Holders of SURFACE ONCOLOGY INC - COM (SURF) as of Q4 2022
As of 31 Dec 2022,
SURFACE ONCOLOGY INC - COM (SURF) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,557,874 shares.
The largest 10 holders included
ARK Investment Management LLC, EcoR1 Capital, LLC, Atlas Venture Associates IX, LLC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., CITIGROUP INC, and DAFNA Capital Management LLC.
This page lists
75
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.